Literature DB >> 24560287

A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.

Andriy Fedorov1, Jacob Fluckiger2, Gregory D Ayers3, Xia Li4, Sandeep N Gupta5, Clare Tempany6, Robert Mulkern7, Thomas E Yankeelov8, Fiona M Fennessy6.   

Abstract

Multi-parametric Magnetic Resonance Imaging, and specifically Dynamic Contrast Enhanced (DCE) MRI, play increasingly important roles in detection and staging of prostate cancer (PCa). One of the actively investigated approaches to DCE MRI analysis involves pharmacokinetic (PK) modeling to extract quantitative parameters that may be related to microvascular properties of the tissue. It is well-known that the prescribed arterial blood plasma concentration (or Arterial Input Function, AIF) input can have significant effects on the parameters estimated by PK modeling. The purpose of our study was to investigate such effects in DCE MRI data acquired in a typical clinical PCa setting. First, we investigated how the choice of a semi-automated or fully automated image-based individualized AIF (iAIF) estimation method affects the PK parameter values; and second, we examined the use of method-specific averaged AIF (cohort-based, or cAIF) as a means to attenuate the differences between the two AIF estimation methods. Two methods for automated image-based estimation of individualized (patient-specific) AIFs, one of which was previously validated for brain and the other for breast MRI, were compared. cAIFs were constructed by averaging the iAIF curves over the individual patients for each of the two methods. Pharmacokinetic analysis using the Generalized kinetic model and each of the four AIF choices (iAIF and cAIF for each of the two image-based AIF estimation approaches) was applied to derive the volume transfer rate (K(trans)) and extravascular extracellular volume fraction (ve) in the areas of prostate tumor. Differences between the parameters obtained using iAIF and cAIF for a given method (intra-method comparison) as well as inter-method differences were quantified. The study utilized DCE MRI data collected in 17 patients with histologically confirmed PCa. Comparison at the level of the tumor region of interest (ROI) showed that the two automated methods resulted in significantly different (p<0.05) mean estimates of ve, but not of K(trans). Comparing cAIF, different estimates for both ve, and K(trans) were obtained. Intra-method comparison between the iAIF- and cAIF-driven analyses showed the lack of effect on ve, while K(trans) values were significantly different for one of the methods. Our results indicate that the choice of the algorithm used for automated image-based AIF determination can lead to significant differences in the values of the estimated PK parameters. K(trans) estimates are more sensitive to the choice between cAIF/iAIF as compared to ve, leading to potentially significant differences depending on the AIF method. These observations may have practical consequences in evaluating the PK analysis results obtained in a multi-site setting.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arterial Input Function; DCE-MRI; Pharmacokinetic modeling; Prostate cancer; Quantitative imaging

Mesh:

Substances:

Year:  2014        PMID: 24560287      PMCID: PMC3965600          DOI: 10.1016/j.mri.2014.01.004

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  33 in total

1.  The effects of renal variation upon measurements of perfusion and leakage volume in breast tumours.

Authors:  T S Ahearn; R T Staff; T W Redpath; S I K Semple
Journal:  Phys Med Biol       Date:  2004-05-21       Impact factor: 3.609

2.  MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results.

Authors:  Cedric M J de Bazelaire; Guillaume D Duhamel; Neil M Rofsky; David C Alsop
Journal:  Radiology       Date:  2004-03       Impact factor: 11.105

Review 3.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

4.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

Authors:  H J Weinmann; M Laniado; W Mützel
Journal:  Physiol Chem Phys Med NMR       Date:  1984

5.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.

Authors:  Catherine Roy; Fatah Foudi; Jeanne Charton; Michel Jung; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

7.  Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity.

Authors:  M K Brawer; R E Deering; M Brown; S D Preston; S A Bigler
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

8.  Temporal sampling requirements for the tracer kinetics modeling of breast disease.

Authors:  E Henderson; B K Rutt; T Y Lee
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

Review 9.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  17 in total

1.  Modification of population based arterial input function to incorporate individual variation.

Authors:  Harrison Kim
Journal:  Magn Reson Imaging       Date:  2017-09-27       Impact factor: 2.546

2.  Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate.

Authors:  Soudabeh Kargar; Eric A Borisch; Adam T Froemming; Akira Kawashima; Lance A Mynderse; Eric G Stinson; Joshua D Trzasko; Stephen J Riederer
Journal:  Magn Reson Imaging       Date:  2017-12-24       Impact factor: 2.546

3.  Bolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Alireza Mehrtash; Sandeep N Gupta; Dattesh Shanbhag; James V Miller; Tina Kapur; Fiona M Fennessy; Ron Kikinis; Andriy Fedorov
Journal:  J Med Imaging (Bellingham)       Date:  2016-03-01

4.  Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study.

Authors:  Octavia Bane; Stefanie J Hectors; Mathilde Wagner; Lori L Arlinghaus; Madhava P Aryal; Yue Cao; Thomas L Chenevert; Fiona Fennessy; Wei Huang; Nola M Hylton; Jayashree Kalpathy-Cramer; Kathryn E Keenan; Dariya I Malyarenko; Robert V Mulkern; David C Newitt; Stephen E Russek; Karl F Stupic; Alina Tudorica; Lisa J Wilmes; Thomas E Yankeelov; Yi-Fei Yen; Michael A Boss; Bachir Taouli
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

5.  Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.

Authors:  Fiona M Fennessy; Andriy Fedorov; Tobias Penzkofer; Kyung Won Kim; Michelle S Hirsch; Mark G Vangel; Paul Masry; Trevor A Flood; Ming-Ching Chang; Clare M Tempany; Robert V Mulkern; Sandeep N Gupta
Journal:  Magn Reson Imaging       Date:  2015-02-14       Impact factor: 2.546

6.  Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.

Authors:  Anna G Sorace; Savannah C Partridge; Xia Li; Jack Virostko; Stephanie L Barnes; Daniel S Hippe; Wei Huang; Thomas E Yankeelov
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

7.  Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.

Authors:  Sharon Peled; Mark Vangel; Ron Kikinis; Clare M Tempany; Fiona M Fennessy; Andrey Fedorov
Journal:  Acad Radiol       Date:  2018-11-20       Impact factor: 3.173

8.  Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive.

Authors:  Jayashree Kalpathy-Cramer; John Blake Freymann; Justin Stephen Kirby; Paul Eugene Kinahan; Fred William Prior
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 9.  Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Authors:  Lizhi Liu; Zhiqiang Tian; Zhenfeng Zhang; Baowei Fei
Journal:  Acad Radiol       Date:  2016-04-25       Impact factor: 3.173

10.  Thapsigargin induces apoptosis of prostate cancer through cofilin-1 and paxillin.

Authors:  Fengyu Huang; Peitao Wang; Xinsheng Wang
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.